4Di Rocco R J, Bauer AA, Pirro JP, et al. Delineation of the border zone of ischemic rabbit yuocardium by a technetium-labeled nitroimidazole. Nuclear Medicine & Biology, 1997, 24:201-207.
5Sinusas AJ. The potential for myocardial imaging with hyoxia markers. Semin Nucl Med, 1999, 29: 330-338.
6Brauers G, Archer CM, Burke JF. The chemical characterization of the tumor imaging agent^99m Tc-HL91 [abstract] .Eur J Nucl Med, 1997,24:943.
7Okada RD, Johnson G, Nguyen KN, et al.^99mTc-HL91 Effects of low flow and hypoxia on a new ischemia-avid myocardial imaging agent. Circulation, 1997,95 : 1892-1899.
8Okada RD, Johnson G, Nguyen KN, et al. ^99m Tc-HL91 :"hotspot" detection of ischemic myocardium in vivo by gamma camera imaging. Circulation, 1998,97:2557-2566.
9Schoder H, Knight RJ, Kofoed KF, et al. Effects of dichloracetate(DCA) on glucose metabolism in postischaemic myocardium in vivo. Eur J Nucl Med, 1996,23:1046.
10Fukuchi K, Kusuoka H, Yutani K, et al. Assessment of reperfused myocardium using a new ischemia-avid imaging agent, ^99m Tc-HL91 : comparison with myocardial glucose uptake. Eur J Nucl Med, 1998,25:361-366.
3Constantine G,Shan K,Flamm SD,et al.Role of MRI in clinical cardiology.Lancet,2004,363:2162-2217.
4Jahnke C,Paetsch I,Schnackenburg B,et al.Coronary MR angiography with steady-state free precession:individually adapted breath-hold technique versus free-breathing technique.Radiology,2004,232:669-676.
5Schinkel AF,Valkema R,Geleijnse ML,et al.Single-photon emission computed tomography for assessment of myocardial viability.Euro Intervention,2010,6 Suppl:115-22.
6Chen EQ,Maclntyre WJ,Go RT,et al.Myocardial viability studies using fluorine-18-FDG SPECT:a comparison with fluorine-18-FDG PET.J Nucl Med,1997,38:582-586.
7Ghesani M,Depuey EG,Rozanski A.Role of F-18 FDG positron emission tomography(PET)in the assessment of myocardial viability.Echocardiography,2005,22:165-177.
